Relationship of neurotransmitters to the symptoms of major depressive disorder
- PMID: 18494537
Relationship of neurotransmitters to the symptoms of major depressive disorder
Abstract
A relationship appears to exist between the 3 main monoamine neurotransmitters in the brain (i.e., dopamine, norepinephrine, and serotonin) and specific symptoms of major depressive disorder. Specific symptoms are associated with the increase or decrease of specific neurotransmitters, which suggests that specific symptoms of depression could be assigned to specific neurochemical mechanisms, and subsequently specific antidepressant drugs could target symptom-specific neurotransmitters. Research on electroconvulsive therapy has supported a correlation between neurotransmitters and depression symptoms. A 2-dimensional model of neurotransmitter functions is discussed that describes depression as a mixture of 2 separate components--negative affect and the loss of positive affect--that can be considered in relation to the 3 amine neurotransmitters. Owing to the different methods of action of available antidepressant agents and the depression symptoms thought to be associated with dopamine, serotonin, and norepinephrine, current treatments can be targeted toward patients' specific symptoms.
Similar articles
-
[A new concept of antidepressant drugs action: clinical and preclinical data].Psychiatr Pol. 1994 Jan-Feb;28(1):39-50. Psychiatr Pol. 1994. PMID: 7910691 Review. Polish.
-
Emerging drugs for major depressive disorder.Expert Opin Emerg Drugs. 2009 Sep;14(3):439-53. doi: 10.1517/14728210903107751. Expert Opin Emerg Drugs. 2009. PMID: 19637989 Review.
-
[Monoamine's role in depression and possible consequences for the clinical management of the core symptoms of major depression].Riv Psichiatr. 2009 Jan-Feb;44(1):1-14. Riv Psichiatr. 2009. PMID: 20066933 Review. Italian.
-
Biological basis of depression and therapeutic relevance.J Clin Psychiatry. 1991 Jun;52 Suppl:4-10. J Clin Psychiatry. 1991. PMID: 1646793 Review.
-
Models of antidepressant action.J Clin Psychiatry. 1999;60 Suppl 14:16-20; discussion 31-5. J Clin Psychiatry. 1999. PMID: 10408421 Review.
Cited by
-
Low-Level Laser Irradiation Improves Depression-Like Behaviors in Mice.Mol Neurobiol. 2017 Aug;54(6):4551-4559. doi: 10.1007/s12035-016-9983-2. Epub 2016 Jul 5. Mol Neurobiol. 2017. PMID: 27379735 Free PMC article.
-
Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women.Front Psychiatry. 2022 Jan 18;12:797577. doi: 10.3389/fpsyt.2021.797577. eCollection 2021. Front Psychiatry. 2022. PMID: 35115970 Free PMC article. Review.
-
Noradrenergic symptom cluster in depression.Neuropsychiatr Dis Treat. 2011;7(Suppl 1):1-2. doi: 10.2147/NDT.S19611. Epub 2011 May 31. Neuropsychiatr Dis Treat. 2011. PMID: 21750621 Free PMC article. No abstract available.
-
Pathophysiology of Depression: Stingless Bee Honey Promising as an Antidepressant.Molecules. 2022 Aug 10;27(16):5091. doi: 10.3390/molecules27165091. Molecules. 2022. PMID: 36014336 Free PMC article. Review.
-
Screening Utility of the PHQ-2 and PHQ-9 for Depression in College Students: Relationships with Substantive Scales of the MMPI-3.Meas Eval Couns Dev. 2023;56(3):254-264. doi: 10.1080/07481756.2022.2110899. Epub 2022 Sep 9. Meas Eval Couns Dev. 2023. PMID: 37744422 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
